SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001596783-23-000187
Filing Date
2023-12-08
Accepted
2023-12-08 17:07:31
Documents
14
Period of Report
2023-12-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.06: Material Impairments
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A ctlt-20231208.htm   iXBRL 8-K/A 47156
2 EX-99.1 ex991q4fy23financialtabler.htm EX-99.1 888545
3 EX-99.2 ex992q1fy24financialtabler.htm EX-99.2 684634
  Complete submission text file 0001596783-23-000187.txt   1837412

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctlt-20231208.xsd EX-101.SCH 2209
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctlt-20231208_lab.xml EX-101.LAB 24695
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctlt-20231208_pre.xml EX-101.PRE 13095
8 EXTRACTED XBRL INSTANCE DOCUMENT ctlt-20231208_htm.xml XML 2709
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K/A | Act: 34 | File No.: 001-36587 | Film No.: 231476268
SIC: 2834 Pharmaceutical Preparations